no statement of use filed
on 16 Mar 2020
Last Applicant/ Owned by
c/o Jacksons Accountants
Ascot, Berkshire
GB
SL57HL
Serial Number
87082178 filed on 23rd Jun 2016
Registration Number
N/A
Correspondent Address
Susan Neuberger Weller
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The mark consists of the word "CASEBIA", appearing directly below the images of a circle, square and pentagon, presented in an overlapping vertical arrangement. Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, auRead More
Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
No 87082178
No Service/Collective Mark
No 052984402T02
No
No
No
No
No
No
No
No
26.09.02 -
Plain single line squares
26.15.02 -
Plain single or multiple line polygons
The mark consists of the word "CASEBIA", appearing directly below the images of a circle, square and pentagon, presented in an overlapping vertical arrangement.
Status Date | Action Taken |
---|---|
16th Mar 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
16th Mar 2020 | ABANDONMENT - NO USE STATEMENT FILED |
11th Mar 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Mar 2020 | EXTENSION 5 GRANTED |
18th Jul 2019 | EXTENSION 5 FILED |
18th Jul 2019 | TEAS EXTENSION RECEIVED |
18th Jul 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
17th Jan 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
15th Jan 2019 | EXTENSION 4 FILED |
15th Jan 2019 | EXTENSION 4 GRANTED |